This fact sheet summarizes up-to-date information on Maviret. Maviret is a medication used to treat hepatitis C. It is approved in Canada for people with hepatitis C in the following situations:

• those with any genotype of the virus who have never taken direct-acting antiretroviral (DAA) medication
• those with any genotype of the virus who have taken DAA medication with a type of medicine called an NS5A inhibitor or an NS3/4A protease inhibitor (but not both types of medication) and who were not cured of the virus